医药生物行业定期报告:解析国内小核酸研发格局(靶点、技术路线和适应症)

华福证券
Nov 30, 2025

(以下内容从华福证券《医药生物行业定期报告:解析国内小核酸研发格局(靶点、技术路线和适应症)》研报附件原文摘录)投资要点:行情回顾:本周(2025年11月24日-2025年11月28日)中信医药指数上涨2.7%,跑赢沪深300指数1.0pct,在中信一级行业分类中排名第16位;2025年初至今中信医药生物板块指数上涨17.7%,跑赢沪深300指数2.7pct,在中信行业分类中排名第15位。本周涨幅...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10